Hegseth's Testosterone Bit Isn't About Health
Medical experts say the plan could reduce fertility and produce unreliable results, while a federal judge is weighing how it fits existing hormone-treatment bans.
- On July 15, Defense Secretary Pete Hegseth announced mandatory annual testosterone testing for service members 30 and older, arguing the policy will keep troops on "the leading edge of lethality."
- The policy, part of Hegseth's "High-T Department of War" initiative, seeks to combat "Operator Syndrome," a physical and behavioral condition he attributes to soldiers undergoing intense training.
- Dr. Alvin Matsumoto warned that mandatory screening produces unreliable results and may reduce fertility in male soldiers, noting less than 6 percent of men between 30 and 79 have a clinical deficiency.
- In a Monday letter, Democratic senators raised red flags about the initiative, while a federal judge ordered the Trump administration to explain how the plan aligns with existing bans on hormone treatment for transgender service members.
- Combat veteran and war reporter Sebastian Junger challenged the operational necessity, arguing testosterone is a lifestyle issue rather than battlefield requirement; studies from 2019 and 2022 found no performance gains from testosterone injections.
12 Articles
12 Articles
Christian Lehmann is a doctor and writer. For "Liberation", he holds the chronicle of a society affected by health crises and public service. Today, he returns to Pete Hegseth's desire to reboot the manhood, and hence the ability to fight, of American soldiers.
Medical experts argue against Hegseth's testosterone obsession
Medical experts are warning against Defense Secretary Pete Hegseth's controversial testosterone testing policy for service members.Hegseth announced the policy last week, requiring annual testosterone testing for all service members over 30 as part of his "High-T Department of War" initiative.The policy faces legal challenges, with a federal judge ordering the Trump administration to explain how it aligns with existing bans on hormone treatment …
Coverage Details
Bias Distribution
- 89% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
